SCHEMBL2149297

SCHEMBL2149297

O=C(O)c1cncc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.59
NR4A2 P43354 1/20 0.59
NR4A3 Q92570 1/20 0.59
CDC25B P30305 2/20 0.52
WDR5 P61964 1/20 0.50
LDHA P00338 1/20 0.48
ALDH1A1 P00352 3/20 0.44
ALOX15 P16050 1/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30430793 1.00 NR4A1 (0.59) NR4A1NR4A2NR4A3CDC25BWDR5
Hydrochloric Acid SCHEMBL4617820 0.98 NR4A1 (0.57) NR4A1NR4A2NR4A3CDC25BWDR5
SCHEMBL7374228 0.86 CDC25B (0.48) NR4A1NR4A2NR4A3CDC25BWDR5
Bromide SCHEMBL7369447 0.84 CDC25B (0.47) NR4A1NR4A2NR4A3CDC25BMEN1
SCHEMBL5047448 0.83 AKR1C3 (0.46) NR4A1NR4A2NR4A3CDC25BALDH1A1
SCHEMBL30032983 0.83 AKR1C3 (0.46) NR4A1NR4A2NR4A3CDC25BALDH1A1
SCHEMBL8966381 0.82 CYP11B1 (0.43) NR4A1NR4A2NR4A3ALDH1A1KDM4E
SCHEMBL30241191 0.82 KDM4E (0.50) NR4A1NR4A2NR4A3ALDH1A1KDM4E
SCHEMBL7067803 0.82 NR4A1 (0.42) NR4A1NR4A2NR4A3CDC25BALDH1A1
SCHEMBL1121657 0.82 KDM4E (0.50) NR4A1NR4A2NR4A3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115286572-B 4-acyl-isoquinoline derivative and preparation method and application thereof 绍兴文理学院 2023-10-13 CN claimed
CN-111995575-A Preparation method of quinoline amide compound 河南农业大学 2020-11-27 CN claimed
CN-104364235-B Amide derivatives as TTX-S blockers 拉夸里亚创药株式会社 2017-07-04 CN claimed
CN-101781247-B New method for synthesizing substituted 3-quinoline carboxylic acid and analogue UNIV SHANGHAI MARITIME 2013-01-02 CN claimed
CN-101781247-A New method for synthesizing substituted 3-quinoline carboxylic acid and analogue UNIV SHANGHAI MARITIME 2010-07-21 CN claimed
EP-2073799-A2 NOVEL AGENTS OF CALCIUM ION CHANNEL MODULATORS VM Discovery, Inc. (US) 2009-07-01 EP claimed
WO-2008112715-A2 NOVEL AGENTS OF CALCIUM ION CHANNEL MODULATORS VM DISCOVERY INC. (US) 2008-09-18 WO claimed
US-4673682-A ANTIARRYTHMIA AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1987-06-16 US claimed
EP-0105210-B1 ISOQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-04 EP claimed
EP-4722196-A1 CRYSTAL OF VIRAL PROTEASE INHIBITOR AND USE Westlake Pharmaceuticals (Hangzhou) Co., Ltd. (CN) 2026-04-08 EP disclosed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
EP-3856178-B1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2026-03-11 EP disclosed
EP-4695230-A1 PROTEASE INHIBITORS AND USES THEREOF Westlake Pharmaceuticals (Hangzhou) Co., Ltd. (CN) 2026-02-18 EP disclosed
US-20250042889-A1 3CLPRO PROTEASE INHIBITOR SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. (CN) 2025-02-06 US disclosed
WO-1986000898-A1 COMPOUNDS FOR SITE-ENHANCED DELIVERY OF RADIONUCLIDES AND USES THEREOF UNIVERSITY OF FLORIDA (US) 1986-02-13 WO disclosed
US-4540564-A DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER UNIVERSITY OF FLORIDA (US) 1985-09-10 US disclosed
US-4396619-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1983-08-02 US disclosed
US-4382932-A Isoquinolinium substituted cephalosporins ELI LILLY AND COMPANY (US) 1983-05-10 US disclosed
US-4137315-A ANTIMICROBIAL, ANTIFUNGAL, ANTISEPTICS RHONE-POULENC INDUSTRIES (FR) 1979-01-30 US disclosed
US-4053300-A BACTERICIDES PHILAGRO (FR) 1977-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH NR4A1 722/4885NR4A2 1245/4885NR4A3 652/4885
US-20250042889-A1 3CLPRO PROTEASE INHIBITOR ACE, ACE2, CTRL NR4A1 2352/4885NR4A2 3381/4885NR4A3 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.